Dataset Information

Universities and social innovation for global sustainable development as seen from the south.

ABSTRACT: Potential contributions of universities to social innovation are explored with special attention to Southern countries. The normative guide is the notion of Sustainable Human Development understood as stressing the agency of least-advantaged sectors. The main challenges stem from decreasing sustainability and increasing inequality. Their impacts are highly dependent on how the tension between economic growth and environmental protection is managed. Improving actual perspectives demands harnessing advanced knowledge to foster inclusive and frugal innovation. For this to occur, universities need to be main actors. The context in which they act is analyzed with reference to the National Systems of Innovation conceptualization. Possible evolutions of universities as agents of social innovation are discussed with the aid of the Multi-Level Perspective. The importance of the Southern experience of innovating in scarcity conditions is highlighted and illustrated with the specific experience of a Latin American university. The cooperation of universities with weak social actors in ways that involve advanced knowledge appears as a key theoretical issue and as a difficult practical problem for the effective engagement of universities in social innovation. The diverse issues that such engagement needs to integrate conform an ambitious research program, of which the paper aims at giving a first glimpse.

SUBMITTER: Arocena R

PROVIDER: S-EPMC7554489 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Universities and social innovation for global sustainable development as seen from the south.

Arocena Rodrigo R Sutz Judith J

Technological forecasting and social change 20201014

Potential contributions of universities to social innovation are explored with special attention to Southern countries. The normative guide is the notion of Sustainable Human Development understood as stressing the agency of least-advantaged sectors. The main challenges stem from decreasing sustainability and increasing inequality. Their impacts are highly dependent on how the tension between economic growth and environmental protection is managed. Improving actual perspectives demands harnessin ...[more]

PMID: 33071365

Similar Datasets

Project description:BackgroundThere is growing interest in pharmaceutical innovation in low- and middle-income countries (LMICs), but information on existing activities, capacities, and outcomes is scarce. We mapped available data at the global level, and studied the national pharmaceutical innovation systems of Bangladesh and Colombia to shed light on pharmaceutical research and development (R&D) in the Global South, including challenges and prospects, to help fill existing knowledge gaps.MethodsWe gathered and analyzed data from three types of sources: literature, semi-structured interviews with key informants, and publicly available data on R&D funding, R&D scientific capacity measured by human resources, and clinical trial activities.ResultsPharmaceutical R&D activities are occurring in many LMICs, but 16 countries have emerged as frontrunners. Investment in R&D in LMICs has increased in the past decade, particularly from middle-income countries (MICs). Capacity is also growing, with an increase in the number of research organizations and the amount of funding available from external sources. The total number of clinical trials and the proportion of trials in LMICs increased markedly, and there is also growing activity in the earlier, more innovative and riskier Phase 1 and 2 trials. Non-commercial entities comprise the majority of clinical trial funders and sponsors in LMICs. Finally, investments have borne fruit, as indicated by a number of innovative medicines developed in LMICs. The Bangladesh and Colombia country studies showed that there is still a need for both targeted R&D policies to strengthen capacities in the pharmaceutical sector, and more government support to overcome the challenges of a lack of funding and coordination among different actors.ConclusionsBy triangulating between the data sources, it was possible to paint a broad picture of who was involved in pharmaceutical R&D in LMICs, in which particular countries, for which diseases, in which R&D phases, and with what results-as well as how these trends have changed over time. Prioritizing pharmaceutical R&D is an important strategy for better meeting health needs. The trendlines are promising, but focused attention is still needed to realize the potential for greater innovation in the Global South.

Dataset Information

Universities and social innovation for global sustainable development as seen from the south.

Publications

Universities and social innovation for global sustainable development as seen from the south.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets